We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Abuse-Deterrent Labeling for Pfizer’s Embeda Opioid
FDA Approves Abuse-Deterrent Labeling for Pfizer’s Embeda Opioid
Pfizer is the latest company to win approval of opioid abuse-deterrent labeling, after the FDA cautiously okayed new statements about Embeda late Friday.